FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On Januray 5, 2005
Table of Contents
Docket # Title
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1997S-0163 Dietary Supplements, Courtesy Letters (Letters of Objection)
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
1999P-1231 Revise Labeling on Tamoxifen (Nolvadex)
1999P-5106 Identify Sources of Natural Flavorings
2000N-0504 Egg Safety Action Plan
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
2005P-0006 ANDA Suitability Petition for Bumetanide Injection, USP 10mg/40 mL
2005P-0007 ANDA Suitability for Risperidone Orally Disintegrating Tablets, 0.25 mg
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 15169 NBTY Inc. Vol #: 134
LET 15170 NBTY Inc. Vol #: 134
LET 15171 NBTY Inc. Vol #: 134
LET 15172 NBTY Inc. Vol #: 134
LET 15173 NBTY Inc. Vol #: 134
LET 15174 NBTY Inc. Vol #: 134
LET 15175 NBTY Inc. Vol #: 134
LET 15176 NBTY Inc. Vol #: 134
LET 15177 NBTY Inc. Vol #: 134
LET 15178 NBTY Inc. Vol #: 134
LET 15179 NBTY Inc. Vol #: 134
LET 15180 NBTY Inc. Vol #: 134
LET 15181 NBTY Inc. Vol #: 134
LET 15182 NBTY Inc. Vol #: 134
LET 15183 NBTY Inc. Vol #: 134
LET 15184 NBTY Inc. Vol #: 134
LET 15185 NBTY Inc. Vol #: 134
LET 15186 NBTY Inc. Vol #: 134
LET 15187 NBTY Inc. Vol #: 134
LET 15188 NBTY Inc. Vol #: 134
LET 15189 NBTY Inc. Vol #: 134
LET 15190 AdvoCare International, L.P. Vol #: 134
LET 15191 AdvoCare International, L.P. Vol #: 134
LET 15192 AdvoCare International, L.P. Vol #: 134
LET 15193 AdvoCare International, L.P. Vol #: 134
LET 15194 AdvaCare International, L.P. Vol #: 134
LET 15195 Kemin Consumer Care, L.C. Vol #: 134
LET 15196 Leiner Health Products Vol #: 134
LET 15197 NBTY Inc. Vol #: 134
LET 15198 NBTY Inc. Vol #: 134
LET 15199 NBTY Inc. Vol #: 134
LET 15200 NBTY Inc. Vol #: 134
LET 15201 NBTY Inc. Vol #: 134
LET 15202 NBTY Inc. Vol #: 134
LET 15203 NBTY Inc. Vol #: 134
1997S-0163 Dietary Supplements, Courtesy Letters (Letters of Objection)
LET 796 HFS-800 to ImmunAct, Inc Vol #: 24
LET 797 HFS-800 to Source Naturals Vol #: 24
LET 798 HFS-800 to 21st Century Nutritional Products Inc Vol #: 24
LET 799 HFS-800 to NOW Foods Vol #: 24
LET 800 HFS-800 to Market America Inc Vol #: 24
LET 801 HFS-800 to Enzymatic Therapy Vol #: 24
LET 802 HFS-800 to NOW Foods Vol #: 24
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
C 7466 A. Felix Vol #: 319
1999P-1231 Revise Labeling on Tamoxifen (Nolvadex)
PAV 1 HFD-001 to Public Citizen Health Research Group Vol #: 1
1999P-5106 Identify Sources of Natural Flavorings
C 70 Mr and Mrs E. Searcy Vol #: 3
2000N-0504 Egg Safety Action Plan
C 286 K. Wright Vol #: 26
C 287 G. Vorderstrasse Vol #: 26
C 288 G. Finnegan Vol #: 26
C 289 V. Crompton Vol #: 26
C 290 G. Seventson Vol #: 26
C 291 E. Anderson Vol #: 26
C 292 K. Tirigotis Vol #: 26
C 293 Illegible Vol #: 26
C 294 United Egg Vol #: 26
C 295 B. Lamoreaux Vol #: 26
C 296 J. Gemaghty Vol #: 26
C 297 M. Prendergast Vol #: 26
C 298 J. Espoz Vol #: 26
C 299 T. Mason Vol #: 26
C 300 Clancy Associates Vol #: 26
C 301 D. Thater Vol #: 26
C 302 Sparboe Summitt Farms, LLC Vol #: 26
C 303 K. Lopez Vol #: 26
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
EXB 803 Bayer Corporation Vol #: 470
EXB 804 Bayer Corporation Vol #: 470
EXB 805 Bayer Corporation Vol #: 470
EXB 806 Bayer Corporation Vol #: 470
EXB 807 Bayer Corporation Vol #: 470
EXB 808 Bayer Corporation Vol #: 470
EXB 809 Bayer Corporation Vol #: 470
EXB 810 Bayer Corporation Vol #: 470
EXB 811 Bayer Corporation Vol #: 470
EXB 812 Bayer Corporation Vol #: 470
EXB 813 Bayer Corporation Vol #: 470
EXB 814 Bayer Corporation Vol #: 470
EXB 815 Bayer Corporation Vol #: 470
EXB 816 Bayer Corporation Vol #: 470
EXB 817 Bayer Corporation Vol #: 470
EXB 818 Bayer Corporation Vol #: 470
EXB 819 Bayer Corporation Vol #: 470
EXB 820 Bayer Corporation Vol #: 470
EXB 821 Bayer Corporation Vol #: 470
2005P-0006 ANDA Suitability Petition for Bumetanide Injection, USP 10mg/40 mL
ACK 1 HFA-305 to Ben Venue Laboratories Vol #: 1
CP 1
Attachment 1, 2
Ben Venue Laboratories Vol #: 1
2005P-0007 ANDA Suitability for Risperidone Orally Disintegrating Tablets, 0.25 mg
ACK 1 HFA-305 to Lachman Consultant Services, Inc. Vol #: 1
CP 1
Attachment 1, 2, 3
Lachman Consultant Services, Inc. Vol #: 1

Page created on January 6, 2005 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management